Early integration of outpatient palliative care among adults with advanced cancer in a safety-net health system.

Authors

null

Lisa DiMartino

Peter O'Donnell Jr. School of Public Health - UT Southwestern Medical Center, Dallas, TX

Lisa DiMartino , Vincent Merrill , Celette Sugg Skinner , Timothy P. Hogan , Navid Sadeghi , Winnie Wang , Alva Roche-Green , Arthur S. Hong

Organizations

Peter O'Donnell Jr. School of Public Health - UT Southwestern Medical Center, Dallas, TX, UT Southwestern Medical Center, Dallas, TX

Research Funding

American Cancer Society Internal Research Grant

Background: Medically underserved adults with cancer present at later disease stages. The American Society of Clinical Oncology recommends all advanced cancer patients receive early intervention by a palliative care (PC) team soon after diagnosis (within 8 weeks) and during active treatment. Few studies have examined early integration of PC in the outpatient setting among advanced cancer patients within a safety-net system. This study examined patterns of outpatient PC service delivery (referrals and visits) for advanced cancer patients seen in the primary safety-net provider of cancer care for under- and uninsured adults in Dallas, TX. Methods: Patients diagnosed with advanced-stage solid tumor and who had at least one outpatient oncology visit January 1, 2018 to July 31, 2023 at the safety-net system were identified via electronic health record. The primary outcome was timeliness of outpatient PC referral (categorical outcome). Among patients with an outpatient PC referral, we used Kruskal-Wallis to test univariate associations across key characteristics, including age, race/ethnicity, cancer site, preferred language, insurance, and diagnosis year. Further, we used multivariate logistic regression to evaluate associations between key characteristics and completed PC visits among those with any outpatient PC referral. Results: Among 1,572 eligible patients (mean age 59, range: 21-94), 44% were female and 76% were non-White. Diagnoses included lung (20%), gastrointestinal (17%), colorectal (14%), breast (9%), prostate (9%), head/neck (9%), pancreatic (8%), and gynecologic (6%) cancers. Over half (n=870, 55%) of patients received an outpatient PC referral during the study period. Of those with a referral, 486 (56%) patients were referred ≤ 8 weeks of diagnosis, 157 (18%) between 9 and 24 weeks, 105 (12%) between 25 and 52 weeks, and 122 (14%) > 52 weeks. Timeliness of referral varied according to race/ethnicity and cancer type (p<.05; Table). Two-thirds of referred patients (n=576) completed a PC visit during the study period. In the adjusted regression model, compared to males, females had higher odds of completing a PC visit – (aOR, 1.40; 95% CI, 1.01-1.94). Conclusions: Just over half of advanced cancer patients received a referral to the outpatient PC team. Nearly half of referred patients had the referral ordered after 8 weeks of diagnosis. Except for gender, there were no other factors associated with PC visit completion. These findings demonstrate a need and potential for interventions targeting PC service delivery to improve care for underserved cancer patients.

Time from diagnosis to PC referral.*

≤8 Weeks9 - 24 Weeks25 - 52 Weeks> 52 Weeks
Cancer type (%)
Colorectal50161717
Lung6417118
Pancreatic641989
Prostate30171240
Race/ethnicity, (%)
White6614109
Black54221212
Hispanic52171318

Select cancer types shown where significant differences were found.

*p<.05.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2024 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Palliative and Supportive Care

Sub Track

Palliative Care

Citation

JCO Oncol Pract 20, 2024 (suppl 10; abstr 195)

DOI

10.1200/OP.2024.20.10_suppl.195

Abstract #

195

Poster Bd #

B20

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Genitourinary Cancers Symposium

Association between sociodemographic factors and diagnosis of advanced prostate cancer in early life.

First Author: Shayan Smani

Abstract

2023 ASCO Quality Care Symposium

Alternative model to deliver germline genetic testing to patients with advanced prostate cancer (PCa).

First Author: Natalie Marie Reizine

Abstract

2024 ASCO Genitourinary Cancers Symposium

Challenges in patient-centered germline testing delivery for veterans with advanced prostate cancer (APC).

First Author: Daniel H Kwon